help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rabbani, S. A.
Right arrow Articles by Goltzman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rabbani, S. A.
Right arrow Articles by Goltzman, D.

Endocrinology, Vol 136, 5416-5422, Copyright © 1995 by Endocrine Society


ARTICLES

Regulation in vivo of the growth of Leydig cell tumors by antisense ribonucleic acid for parathyroid hormone-related peptide

SA Rabbani, J Gladu, B Liu and D Goltzman
Department of Medicine, McGill University, Montreal, Quebec, Canada.

PTH-related peptide (PTHrP) has been shown to be the major mediator of hypercalcemia of malignancy, but may also exert effects on cell growth and differentiation. The Leydig cell tumor H-500, when implanted in Fischer rats, produces abundant PTHrP and eventually causes the death of the host animal. In the present study we have used antisense RNA technology to block the effects of PTHrP in H-500 Leydig tumor cells in vivo. The full-length rat PTHrP complementary DNA encoding amino acid - 36-->141 was subcloned as an EcoRI-BglII insert in the antisense orientation into the mammalian expression vector pRc/CMV to produce the plasmid pRc-PAS. This plasmid was then stably transfected into the H- 500 Leydig tumor cells with a Lipofectin reagent. After selection with the neomycin derivative G-418, a stable cell line, H-500-PTHrP-AS, was obtained which showed 80% inhibition of endogenous PTHrP messenger RNA compared to wild-type or vector-only transfected H-500 cells. Conditioned culture medium from these experimental cells showed a marked decrease in PTHrP immunoreactivity and in the ability of the medium to stimulate adenylate cyclase in UMR-106 rat osteosarcoma cells. Furthermore, inhibition of PTHrP production resulted in a significant increase in the doubling time of the H-500 cells. Transfection of the experimental plasmid into Rat-2 fibroblasts, which do not produce PTHrP, had no effect on cell growth. Control and experimental cells were then implanted sc into male Fischer rats. Animals were killed at timed intervals, and their tumor volumes were determined. Experimental animals receiving cells transfected with antisense PTHrP plasmid showed near-normal levels of plasma calcium and decreased expression of tumoral PTHrP messenger RNA. These animals also showed a 30-70% lower tumor volume during the course of the experiment compared to control animals. These studies have demonstrated that PTHrP can play a role as a promoter of tumor growth in vitro and in vivo.


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Chattopadhyay
Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E761 - E770.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. H. Hastings, A. M.P. Laux, A. Casillas, R. Xu, Z. Lukas, K. Ernstrom, and L. J. Deftos
Sex-Specific Survival Advantage with Parathyroid Hormone-Related Protein in Non-Small Cell Lung Carcinoma Patients
Clin. Cancer Res., January 15, 2006; 12(2): 499 - 506.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Tfelt-Hansen, A. Ferreira, S. Yano, D. Kanuparthi, J. R. Romero, E. M. Brown, and N. Chattopadhyay
Calcium-sensing receptor activation induces nitric oxide production in H-500 Leydig cancer cells
Am J Physiol Endocrinol Metab, June 1, 2005; 288(6): E1206 - E1213.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Shukeir, A. Arakelian, G. Chen, S. Garde, M. Ruiz, C. Panchal, and S. A. Rabbani
A Synthetic 15-mer Peptide (PCK3145) Derived from Prostate Secretory Protein Can Reduce Tumor Growth, Experimental Skeletal Metastases, and Malignancy-Associated Hypercalcemia
Cancer Res., August 1, 2004; 64(15): 5370 - 5377.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Tfelt-Hansen, P. Schwarz, E. F. Terwilliger, E. M. Brown, and N. Chattopadhyay
Calcium-Sensing Receptor Induces Messenger Ribonucleic Acid of Human Securin, Pituitary Tumor Transforming Gene, in Rat Testicular Cancer
Endocrinology, December 1, 2003; 144(12): 5188 - 5193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Tfelt-Hansen, R. J. MacLeod, N. Chattopadhyay, S. Yano, S. Quinn, X. Ren, E. F. Terwilliger, P. Schwarz, and E. M. Brown
Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells
Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E329 - E337.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Shukeir, A. Arakelian, S. Kadhim, S. Garde, and S. A. Rabbani
Prostate Secretory Protein PSP-94 Decreases Tumor Growth and Hypercalcemia of Malignancy in a Syngenic in Vivo Model of Prostate Cancer
Cancer Res., May 1, 2003; 63(9): 2072 - 2078.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. L. Sanders, N. Chattopadhyay, O. Kifor, T. Yamaguchi, and E. M. Brown
Ca2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1267 - E1274.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. Richard, M. D. Lairmore, P. L. Green, G. Feuer, R. S. Erbe, B. Albrecht, C. D'Souza, E. T. Keller, J. Dai, and T. J. Rosol
Humoral Hypercalcemia of Malignancy : Severe Combined Immunodeficient/Beige Mouse Model of Adult T-Cell Lymphoma Independent of Human T-Cell Lymphotropic Virus Type-1 Tax Expression
Am. J. Pathol., June 1, 2001; 158(6): 2219 - 2228.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. L. Sanders, N. Chattopadhyay, O. Kifor, T. Yamaguchi, R. R. Butters, and E. M. Brown
Extracellular Calcium-Sensing Receptor Expression and Its Potential Role in Regulating Parathyroid Hormone-Related Peptide Secretion in Human Breast Cancer Cell Lines
Endocrinology, December 1, 2000; 141(12): 4357 - 4364.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Falzon and P. Du
Enhanced Growth of MCF-7 Breast Cancer Cells Overexpressing Parathyroid Hormone-Related Peptide
Endocrinology, May 1, 2000; 141(5): 1882 - 1892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. E. Abdaimi, V. Papavasiliou, S. A. Rabbani, J. S. Rhim, D. Goltzman, and R. Kremer
Reversal of Hypercalcemia with the Vitamin D Analogue EB1089 in a Human Model of Squamous Cancer
Cancer Res., July 1, 1999; 59(14): 3325 - 3328.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Meerovitch, S. Wing, and D. Goltzman
Proparathyroid Hormone-related Protein Is Associated with the Chaperone Protein BiP and Undergoes Proteasome-mediated Degradation
J. Biol. Chem., August 14, 1998; 273(33): 21025 - 21030.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Meerovitch, S. Wing, and D. Goltzman
Preproparathyroid Hormone-related Protein, a Secreted Peptide, Is a Substrate for the Ubiquitin Proteolytic System
J. Biol. Chem., March 7, 1997; 272(10): 6706 - 6713.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Dittmer, C. A. Pise-Masison, K. E. Clemens, K.-S. Choi, and J. N. Brady
Interaction of Human T-cell Lymphotropic Virus Type I Tax, Ets1, and Sp1 in Transactivation of the PTHrP P2 Promoter
J. Biol. Chem., February 21, 1997; 272(8): 4953 - 4958.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society